C. PreeyasombatP. SiripoonyaA. TejavejN. PitchayayothinMahidol University2018-04-192018-04-191975-01-01Journal of the Medical Association of Thailand. Vol.58, No.3 (1975), 161-170012522082-s2.0-0016477404https://repository.li.mahidol.ac.th/handle/123456789/10815A type 4, female pseudohermaphrodite due to virilizing congenital adrenal hyperplasia resulting from 21 β hydroxylase deficiency was reported. Salt losing manifestations developed within the first month of life. The salt losing adrenal insufficiency was well controlled by glucocorticoid, mineralocorticoid and additional salt therapy. Methods for correct diagnosis and selection of proper sex for rearing are discussed. Long term follow up and treatment were planned including hormone therapy, surgical correction of external genitalia, considering growth and development, as well as the psychological aspect.Mahidol UniversityMedicineA female pseudohermaphrodite with salt losing congenital adrenal hyperplasia as the result of 21 β OH deficiencyArticleSCOPUS